Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Cash from Operations came in at $28.9 million in Q2 2026, up 32.57% on a YoY basis from $21.8 million in Q2 2025, and up 270.0% quarter-over-quarter from -$17.0 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Cash from Operations for 5 consecutive years, with $28.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Operations rose 32.57% year-over-year to $28.9 million; the trailing twelve-month figure through Jun 2026 stood at $227.8 million (up 359.75% YoY), and the FY2025 full-year result was $113.5 million, down 56.81% from the prior year.
- Cash from Operations climbed to $28.9 million in Q2 2026 per FTRE's latest filing, from -$17.0 million in the prior quarter.
- Across five years, Cash from Operations topped out at $273.7 million in Q2 2024 and bottomed at -$124.2 million in Q1 2025.
- Historically, Cash from Operations has averaged $41.3 million across 5 years, with a median of $20.1 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations slumped 1180.0% in 2024, then soared 3716.67% in 2025.
- Over 5 years, Cash from Operations stood at $23.5 million in 2022, then decreased by 21.7% to $18.4 million in 2023, then dropped by 7.07% to $17.1 million in 2024, then jumped by 654.97% to $129.1 million in 2025, then plunged by 77.61% to $28.9 million in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered $28.9 million, -$17.0 million, and $129.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 162.01 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 281.27 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 179.73 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 28.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -44.27 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -492,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.90 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Dec 31, 2025 | 129.10 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Jun 30, 2025 | 21.80 Mn |
| Mar 31, 2025 | -124.20 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 273.70 Mn |
| Mar 31, 2024 | -25.60 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 150.10 Mn |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 23.50 Mn |
| Sep 30, 2022 | 80.90 Mn |